Advertisement

Topics

BioImage A/S Company Profile

03:55 EDT 19th October 2018 | BioPortfolio

BioImage A/S uses its expertise in redistributionâ„¢ technologies to discover drug candidates that change the activity of specific signaling pathways without inhibiting the catalytic activity of signaling proteins. Increased or decreased activity of a pathway is achieved by targeting the exquisitely specific interactions by which signaling proteins control cellular information flow. BioImage specialises in discovering leads against known signaling targets that cannot be inhibited with absolute specificity by traditional means. The Company's high-throughput cell-based redistribution assays make these targets amenable to drug discovery.

BioImage's technologies enable the discovery of drugs that precisely target individual signaling proteins. Drugs with this new mode of action will demonstrate completely different selectivity profiles compared to traditional active-site inhibitors, and are likely to produce fewer side effects. The Company's novel approach offers exceptional target and drug discovery opportunities in most therapeutic areas. BioImage is currently focused on inflammatory and autoimmune diseases, diabetes, cancers and cardiovascular diseases.



BioImage has developed proprietary cell-based imaging technologies that allow protein interactions and translocations to be visualized in living cells in real time using high-throughput, automated redistribution assays. BioImage is the first company to discover new drug targets and drug candidates in this way. The Company will co-develop the output of its discovery efforts with pharmaceutical partners to produce novel therapeutics.

Location

Moerkhoej Bygade 28
Soeborg
DK-2860
Denmark

Contact

Phone: +45 44 43 34 44
Fax: +45 44 43 75 05
Email: info@bioimage.dk


Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Quantitative bioimage analysis of cell characteristics.

In vivo characterization of light scattering properties of human skin in the 475- to 850-nm wavelength range in a Swedish cohort.

We have determined in vivo optical scattering properties of normal human skin in 1734 subjects, mostly with fair skin type, within the Swedish CArdioPulmonary bioImage Study. The measurements were per...

Microscopy in infectious disease research - imaging across scales.

A comprehensive understanding of host-pathogen interactions requires quantitative assessment of molecular events across a wide range of spatiotemporal scales and organizational complexities. Due to re...

Three-Dimensional Quantification of Filopodia in Motile Cancer Cells.

We present a three-dimensional bioimage analysis workflow to quantitatively analyze single, actin-stained cells with filopodial protrusions of diverse structural and temporal attributes, such as numbe...

SPF-CellTracker: Tracking multiple cells with strongly-correlated moves using a spatial particle filter.

Tracking many cells in time-lapse 3D image sequences is an important challenging task of bioimage informatics. Motivated by a study of brain-wide 4D imaging of neural activity in C. elegans, we presen...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Natural History of Carotid Plaque as Determined by 3D Ultrasound

This proposed follow-up study aims to recruit participants from the original BioImage cohort for a one-time follow-up examination. The repeat ultrasound scan of the carotid arteries will p...

BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

The BioImage Study is a study of the characteristics of subclinical cardiovascular disease, as measured by imaging modalities, unsupervised circulating biomarker measurements, and risk fac...

BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study

Obstructive lung disease is an increasing global health problem of pandemic proportions, with COPD alone affecting >10% of the population. Smoking is the main and most well studies risk fa...

Companies [2 Associated Companies listed on BioPortfolio]

BioImage A/S

BioImage A/S uses its expertise in redistributionâ„¢ technologies to discover drug candidates that change the activity of specific signaling pathways without inhibiting the catalytic activity of s...

Fisher BioImage ApS

BioImage is a life science company that has pioneered the field of High Content Pathway Analysis. We provide products, services, and broadly-enabling licenses to the life science market that are based...

More Information about "BioImage A/S" on BioPortfolio

We have published hundreds of BioImage A/S news stories on BioPortfolio along with dozens of BioImage A/S Clinical Trials and PubMed Articles about BioImage A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioImage A/S Companies in our database. You can also find out about relevant BioImage A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record